MedMira Historical Financial Ratios

MIR Stock  CAD 0.08  0.00  0.00%   
MedMira is lately reporting on over 86 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Average Payables of 1.8 M will help investors to properly organize and evaluate MedMira financial condition quickly.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MedMira. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About MedMira Financial Ratios Analysis

MedMiraFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate MedMira investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on MedMira financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across MedMira history.

MedMira Financial Ratios Chart

At this time, MedMira's Price To Sales Ratio is fairly stable compared to the past year. Days Sales Outstanding is likely to climb to 1,237 in 2024, whereas Book Value Per Share is likely to drop (0.02) in 2024.
Add Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Dividend YieldEarnings Yield
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing MedMira stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on MedMira sales, a figure that is much harder to manipulate than other MedMira multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Average Inventory

The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.

Return On Tangible Assets

A profitability metric that measures a company's ability to generate earnings from its tangible assets.
Most ratios from MedMira's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into MedMira current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MedMira. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, MedMira's Price To Sales Ratio is fairly stable compared to the past year. Days Sales Outstanding is likely to climb to 1,237 in 2024, whereas Book Value Per Share is likely to drop (0.02) in 2024.
 2021 2022 2023 2024 (projected)
Payables Turnover0.240.270.06850.0651
Days Of Inventory On Hand113.7476.76349.22331.76

MedMira fundamentals Correlations

-0.860.9-0.920.16-0.9-0.60.4-0.860.96-0.91-0.21-0.4-0.910.910.150.910.9-0.91-0.240.35-0.340.1-0.150.250.49
-0.86-0.60.7-0.270.680.42-0.181.0-0.860.680.110.280.69-0.69-0.17-0.7-0.610.690.62-0.310.36-0.030.32-0.05-0.41
0.9-0.6-0.860.17-0.85-0.450.54-0.60.82-0.85-0.21-0.33-0.850.860.130.840.94-0.860.120.28-0.20.2-0.080.460.46
-0.920.7-0.86-0.050.990.74-0.230.7-0.950.990.120.350.97-0.99-0.26-0.99-0.890.99-0.05-0.420.12-0.010.23-0.39-0.47
0.16-0.270.17-0.050.050.340.19-0.270.080.06-0.13-0.080.08-0.03-0.26-0.030.080.04-0.320.36-0.02-0.38-0.010.01-0.44
-0.90.68-0.850.990.050.77-0.210.68-0.941.00.010.280.99-1.0-0.36-1.0-0.891.0-0.11-0.290.06-0.10.3-0.44-0.6
-0.60.42-0.450.740.340.77-0.120.42-0.650.76-0.060.310.74-0.76-0.31-0.76-0.640.75-0.09-0.090.070.110.1-0.19-0.48
0.4-0.180.54-0.230.19-0.21-0.12-0.180.16-0.22-0.23-0.32-0.220.23-0.190.210.63-0.220.00.03-0.620.130.470.30.09
-0.861.0-0.60.7-0.270.680.42-0.18-0.860.680.110.280.69-0.69-0.17-0.7-0.610.690.62-0.310.36-0.030.32-0.05-0.41
0.96-0.860.82-0.950.08-0.94-0.650.16-0.86-0.94-0.14-0.34-0.940.940.240.940.81-0.94-0.210.38-0.190.08-0.290.220.52
-0.910.68-0.850.990.061.00.76-0.220.68-0.940.030.30.99-1.0-0.35-1.0-0.891.0-0.1-0.290.07-0.120.29-0.43-0.6
-0.210.11-0.210.12-0.130.01-0.06-0.230.11-0.140.030.68-0.02-0.050.77-0.05-0.140.040.23-0.630.40.17-0.580.170.52
-0.40.28-0.330.35-0.080.280.31-0.320.28-0.340.30.680.27-0.330.72-0.32-0.390.310.19-0.40.480.15-0.610.080.12
-0.910.69-0.850.970.080.990.74-0.220.69-0.940.99-0.020.27-0.99-0.38-0.99-0.890.99-0.08-0.220.09-0.210.3-0.41-0.67
0.91-0.690.86-0.99-0.03-1.0-0.760.23-0.690.94-1.0-0.05-0.33-0.990.321.00.9-1.00.080.31-0.090.11-0.250.410.58
0.15-0.170.13-0.26-0.26-0.36-0.31-0.19-0.170.24-0.350.770.72-0.380.320.330.17-0.340.22-0.330.40.2-0.750.340.65
0.91-0.70.84-0.99-0.03-1.0-0.760.21-0.70.94-1.0-0.05-0.32-0.991.00.330.89-1.00.070.33-0.10.09-0.270.420.57
0.9-0.610.94-0.890.08-0.89-0.640.63-0.610.81-0.89-0.14-0.39-0.890.90.170.89-0.890.10.24-0.320.160.00.480.5
-0.910.69-0.860.990.041.00.75-0.220.69-0.941.00.040.310.99-1.0-0.34-1.0-0.89-0.08-0.30.09-0.140.28-0.42-0.6
-0.240.620.12-0.05-0.32-0.11-0.090.00.62-0.21-0.10.230.19-0.080.080.220.070.1-0.08-0.240.520.15-0.010.570.15
0.35-0.310.28-0.420.36-0.29-0.090.03-0.310.38-0.29-0.63-0.4-0.220.31-0.330.330.24-0.3-0.24-0.3-0.410.23-0.09-0.45
-0.340.36-0.20.12-0.020.060.07-0.620.36-0.190.070.40.480.09-0.090.4-0.1-0.320.090.52-0.3-0.08-0.590.280.07
0.1-0.030.2-0.01-0.38-0.10.110.13-0.030.08-0.120.170.15-0.210.110.20.090.16-0.140.15-0.41-0.08-0.050.090.6
-0.150.32-0.080.23-0.010.30.10.470.32-0.290.29-0.58-0.610.3-0.25-0.75-0.270.00.28-0.010.23-0.59-0.05-0.35-0.44
0.25-0.050.46-0.390.01-0.44-0.190.3-0.050.22-0.430.170.08-0.410.410.340.420.48-0.420.57-0.090.280.09-0.350.31
0.49-0.410.46-0.47-0.44-0.6-0.480.09-0.410.52-0.60.520.12-0.670.580.650.570.5-0.60.15-0.450.070.6-0.440.31
Click cells to compare fundamentals

MedMira Account Relationship Matchups

MedMira fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio300.8636.8492.93145.12166.89175.24
Ptb Ratio(17.77)(5.02)(7.16)(4.18)(3.76)(3.95)
Days Sales Outstanding82.53212.87524.831.2K1.2K1.2K
Book Value Per Share(0.0236)(0.0239)(0.0182)(0.0216)(0.0194)(0.0204)
Free Cash Flow Yield(0.001511)(0.006851)(0.0221)(0.0202)(0.0182)(0.0191)
Operating Cash Flow Per Share(4.8E-4)(7.67E-4)(0.002768)(0.001818)(0.001636)(0.001718)
Average Payables2.0M2.5M2.7M3.0M2.7M1.8M
Pb Ratio(17.77)(5.02)(7.16)(4.18)(3.76)(3.95)
Ev To Sales313.3843.29101.61166.5318.0917.18
Free Cash Flow Per Share(6.35E-4)(8.22E-4)(0.00287)(0.00182)(0.001638)(0.001719)
Roic0.210.03520.260.250.230.22
Inventory Turnover1.561.793.214.761.051.92
Net Income Per Share(0.003107)(0.001027)(0.002691)(0.003836)(0.003453)(0.003625)
Days Of Inventory On Hand234.27203.58113.7476.76349.22331.76
Payables Turnover0.150.160.240.270.06850.0651
Sales General And Administrative To Revenue1.270.230.771.952.92.18
Research And Ddevelopement To Revenue0.220.170.21.091.161.49
Cash Per Share6.1E-4(0.003499)4.9E-51.9E-51.7E-51.8E-5
Pocfratio(875.33)(156.55)(46.97)(49.51)(56.94)(59.79)
Interest Coverage(1.79)(0.28)(2.63)(2.2)(2.92)(3.06)
Pfcf Ratio(661.87)(145.97)(45.29)(49.46)(56.88)(59.73)
Days Payables Outstanding2.4K2.3K1.5K1.4K5.3K5.6K
Income Quality0.150.751.030.470.880.72
Roe0.220.160.130.0430.150.18
Ev To Operating Cash Flow(911.76)(183.97)(51.35)(56.82)(2.54)(2.67)
Pe Ratio(135.19)(116.9)(48.31)(23.46)(26.98)(28.33)
Return On Tangible Assets(0.6)(0.17)(0.48)(0.73)(0.55)(0.58)
Ev To Free Cash Flow(689.41)(171.55)(49.52)(56.76)(2.03)(2.13)
Net Debt To E B I T D A(10.22)74.69(7.74)(5.87)(3.5)(3.32)
Current Ratio0.01780.05760.09050.120.110.18
Tangible Book Value Per Share(0.0236)(0.0239)(0.0182)(0.0216)(0.0194)(0.0204)
Receivables Turnover4.421.710.70.30.310.29
Graham Number0.04060.02350.03320.04310.04960.0471
Shareholders Equity Per Share(0.0236)(0.0239)(0.0182)(0.0216)(0.0194)(0.0204)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MedMira Stock Analysis

When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.